Herpes Labialis News and Research

RSS
Herpes labialis or "orolabial herpes" is an infection of the lip by herpes simplex virus. An outbreak typically causes small blisters or sores on or around the mouth commonly known as cold sores or fever blisters.
BioAlliance Pharma, Daewoong sign new licensing agreement for commercialization of Sitavig in South Korea

BioAlliance Pharma, Daewoong sign new licensing agreement for commercialization of Sitavig in South Korea

European Commission grants orphan drug designation for maribavir for treatment of CMV disease

European Commission grants orphan drug designation for maribavir for treatment of CMV disease

EADV spring symposium: Bioalliance Pharma presents Sitavig study results

EADV spring symposium: Bioalliance Pharma presents Sitavig study results

NanoBio to present data from preclinical studies at 8th Annual International RSV Symposium

NanoBio to present data from preclinical studies at 8th Annual International RSV Symposium

ViroPharma initiates maribavir Phase 2 program for CMV infections

ViroPharma initiates maribavir Phase 2 program for CMV infections

GSK launches Medivir's Xerclear for OTC use in Europe

GSK launches Medivir's Xerclear for OTC use in Europe

PLoS One publishes data from recent animal studies of NanoBio's intranasal RSV vaccine

PLoS One publishes data from recent animal studies of NanoBio's intranasal RSV vaccine

NIH, NanoBio sign licensing agreement to develop vaccine against RSV infections

NIH, NanoBio sign licensing agreement to develop vaccine against RSV infections

Clinical Vaccine Immunology publishes NanoBio's NB-1008 influenza study results

Clinical Vaccine Immunology publishes NanoBio's NB-1008 influenza study results

Medivir, Meda renegotiate agreement for cold sores medicine, Xerese

Medivir, Meda renegotiate agreement for cold sores medicine, Xerese

Daewoong, Medivir sign distribution agreement for Xerclear in China and Hong Kong

Daewoong, Medivir sign distribution agreement for Xerclear in China and Hong Kong

GSK, NanoBio initiate two NB-001 Phase 3 trials in cold sores

GSK, NanoBio initiate two NB-001 Phase 3 trials in cold sores

Watson introduces Famciclovir tablets to treat cold sores, genital herpes

Watson introduces Famciclovir tablets to treat cold sores, genital herpes

Meda launches Medivir's cold sore treatment Xerese in the U.S.

Meda launches Medivir's cold sore treatment Xerese in the U.S.

Bill & Melinda Gates Foundation awards $6M grant to NanoBio to develop intranasal vaccine for RSV

Bill & Melinda Gates Foundation awards $6M grant to NanoBio to develop intranasal vaccine for RSV

DoD awards $1.5 million grant to study nanoemulsion-based therapies for preventing burn wound infections

DoD awards $1.5 million grant to study nanoemulsion-based therapies for preventing burn wound infections

New American Therapeutics acquires U.S. rights to market Denavir drug

New American Therapeutics acquires U.S. rights to market Denavir drug

NanoBio Corporation to present Nanoemulsion Phase I clinical trial data at ICAAC Conference

NanoBio Corporation to present Nanoemulsion Phase I clinical trial data at ICAAC Conference

BioAlliance Pharma receives European patent for acyclovir Lauriad tablets for recurrent herpes labialis

BioAlliance Pharma receives European patent for acyclovir Lauriad tablets for recurrent herpes labialis

FDA notification confirms acyclovir Lauriad for oro-facial herpes labialis

FDA notification confirms acyclovir Lauriad for oro-facial herpes labialis